RANDOMIZED TRIAL OF CISPLATIN (C), METHOTREXATE (A), BLEOMYCIN (B) AND VINCRISTINE (O) VS ABO IN SQUAMOUS-CELL HEAD AND NECK-CANCER | AMiner